联邦制药

3933 Public

HKEX exchange • Created Jan 14, 2026

Financial reports

Public filings from SEC EDGAR and company websites.

AI reports

Completed valuation analysis reports.

Last cutoff

Dec 31, 2024

Most recent financial reporting period.

Ticker price

HKD 13.20

Updated Mar 6, 2026

Fair value

??? (Subscribe to view)

Updated —

AI-generated reports

Track completed analysis reports.

Report name	Report date	Language	Fair value
2025年估值分析	Dec 31, 2024	中文	??? (Subscribe to view)

Editorial coverage tied to this company.

Mar 1, 2026

联邦制药由集采导致的盈利下滑压力已基本得到释放，风险处于“接近出清”的状态，且由于业务结构的优化，抗风险能力显著增强。

Article

Public filings from SEC EDGAR and company websites.

Report name	Report date	Language
20241231_zh.pdf	Dec 31, 2024	ZH